Scholarly Index
Elisabetta Leo
AstraZeneca (United Kingdom); 4,823 total citations; 74 total publications; best world rank #459
AstraZeneca (United Kingdom)
4,823Total citations
74Total publications
29H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 760 | GB 67 | 92.36 |
| PARP inhibition in cancer therapy | 2021-2025 | 459 | GB 45 | 87.63 |